-
Bridge Biotherapeutics readies third IPO try after clinching mega dealIndustryAug 1, 2019‘No research, development only’ company proves potential through W1.5tr license-out deal with Boehringer Ingelheim -
Avellino Labs aims to set example for Kosdaq listing of US firmsIndustryJun 30, 2019From assisting disease prevention with DNA diagnosis, company aims for potentially curing genetic diseases
MOST POPULAR
-
01S. Korea sees triple-digit gains in daily COVID-19 cases for 2nd day
-
Defense ministry confirms N. Korea shot missing S. Korean official to death02
-
03Seoul strongly condemns Pyongyang, demands explanation for civilian killing
-
Warner Bros. to withdraw from S. Korean market04
-
05S. Korea's new daily COVID-19 bounce back to triple-digit figure
-
Moon calls for UN’s support for ending Korean War06
-
07[Newsmaker] Supreme Court affirms prison terms of singers in rape case
-
Moon’s call for end-of-war declaration ‘out of sync’ with US: experts08
-
09[News Analysis] Are Musk’s EV battery ambitions too good to be true?
-
[Newsmaker] Korean lawmakers to summon Google, Netflix chiefs10